Bernard Fisher revolutionized the understanding of breast cancer—but 28 years ago this week, NCI jettisoned him from his position as chair of the National Surgical Adjuvant Breast and Bowel Project.
Cancer mortality fell by 2.1% between 2018 and 2019, compared to a 2.4% relative decrease in the year prior, according to the American Cancer Society’s 2022 Cancer Statistics report.
The rapid acceleration of drug development has exponentially increased the therapeutic options available to patients with cancer.
With the Russian invasion stalled and with a forceful counter-attack by Ukrainian armed forces, many observers caution that the Kremlin might be considering a show of force much as the U.S. did in the atomic bombings of Hiroshima and Nagasaki (The Cancer Letter, Feb. 25, March 4, March 11, 2022).
Carol Fabian recalls the emotional hardship that came with treating women for breast cancer in the 1970s and eighties.
There is arguably no pair of oncology’s founders more famous than James Holland, longtime chairman of the Acute Leukemia Group B (ALGB), and Jimmie Holland, the founder of psycho-oncology.
Under ordinary circumstances, business arrangements built around the 340B drug discount program remain shrouded in secrecy.
After ferrying her son to safety across the Hungarian border, Nataliia Verovkina has returned to Kyiv to resume treating cancer patients.
Most of these medical pioneers, nicknamed the “Cancer Cowboys” are gone now. Their ranks once included James Holland, Tom Frei and Emil “Jay” Freireich. Arguably, the best known of this group, Donald Pinkel, died March 9 at his home in San Luis Obispo, CA, at the age of 95.
Dr. Donald Pinkel, my father, was a pioneering pediatric oncologist who developed the first curative drug treatment for acute lymphoblastic leukemia (ALL) in children. This work has led to a vastly improved survival rate for ALL patients throughout the world.
